moxisylyte
Sign in to saveMoxisylyte, also known as thymoxamine, is a drug used in urology for the treatment of erectile dysfunction. It is an α1-adrenergic antagonist. In the United Kingdom, Moxisylyte is marketed as Opilon (Archimedes Pharma UK Ltd) and is used for the short-term treatment of primary Raynaud's syndrome. This is a condition where the fingers and toes become discoloured and is triggered by responses to cold, or emotional distress. Opilon tablets help by improving blood circulation to the extremities.
Research
375 papers- Moxisylyte: a review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic use in impotence.Fundamental & clinical pharmacology · 1998
- Raynaud disease.The Journal of hand surgery · 2014
- A review of the clinical pharmacokinetics of pilocarpine, moxisylyte (thymoxamine), and dapiprazole in the reversal of diagnostic pupillary dilation.Optometry and vision science : official publication of the American Academy of Optometry · 1992
- Multiple-dose pharmacokinetics of moxisylyte after oral administration to healthy volunteers.Journal of pharmaceutical sciences · 1993
- [Moxisylyte-induced cytolytic hepatitis?].Gastroenterologie clinique et biologique · 1991
via PubMed
~1 min read
Encyclopedic overview
1 sectionsContents
- References
Moxisylyte, also known as thymoxamine, is a drug used in urology for the treatment of erectile dysfunction. It is an α1-adrenergic antagonist. In the United Kingdom, Moxisylyte is marketed as Opilon (Archimedes Pharma UK Ltd) and is used for the short-term treatment of primary Raynaud's syndrome. This is a condition where the fingers and toes become discoloured and is triggered by responses to cold, or emotional distress. Opilon tablets help by improving blood circulation to the extremities.
==References==
Excerpted from Wikipedia’s “moxisylyte” article, available under the CC BY-SA 4.0 licence.
Available in 7 languages
via Wikidata sitelinks · CC0